Abstract. The precursor protein of von Willebrand factor (pro-vWF) consists of four different repeated domains, denoted
T HE routing of secretory and membrane proteins through the cell depends both on information contained in the poly-peptide chain and on the ability of the cell to respond to this information (Munro and Pelham, 1987; Gould et al., 1987; Medda et al., 1989) . Besides the information contained by the primary amino acid sequence of a protein, other parameters are of importance for correct routing of secretory and membrane proteins (for review see Lodish, 1988; Rose and Doms, 1988; Hurtley and Helenius, 1989) . Using the influenza virus hemagglutinin, it has been shown that correct folding upon translation in the ER is a prerequisite for transport through the cell (Gething et al., 1986; Copeland et al., 1988) . In addition, for oligomeric proteins, as for example immunoglobulins and the T cell receptor, correct assembly appears to be an absolute prerequisite for normal routing (Bole et al., 1986; Gething et al., 1986; Copeland et al., 1988; Lippincott-Schwartz et al., 1988) . The assembly of oligomers occurs in the ER where apparently a discrimination is made between correctly assembled and unassembled proteins. Recently, a group of ER-resident proteins, termed polypeptide chain binding (PCB) 1 proteins, 1. Abbreviations used in this paper: IPB, immunopreeipitation buffer; PCB, polypeptide chain binding; vWF, yon WiUebrand factor. have been implicated in this discriminatory process (for review see Rothman, 1989) .
von Willebrand factor (vWF), a large, adhesive glycoprotein involved in the adhesion of platelets to a damaged vessel wall, is yet another protein assembled in the ER into dimers (Wagner and Marder, 1984) . The vWF protein is synthesized in megakaryocytes and endothelial cells, and its biosynthesis has been studied extensively (for review see Verweij, 1988a) . A unique property of the vWF protein is that, in addition to dimer formation, it is able to assemble into a heterogeneous series of multimeric structures with molecular weights ranging from 400,000 to 20,000,000 (Van Mourik and Bolhuis, 1978; Hoyer and Shainoff, 1980; Ruggeri and Zimmerman, 1981) . Assembly of dimers into multimeric vWF has been localized to the Golgi apparatus (Wagner and Marder, 1984) . In this compartment, part of the multimers is packaged into specialized organdies, the so-called Weibel-Palade bodies and another part of the vWF protein, consisting of relatively small multimers, is secreted constitutively (Loesberg et al., 1983; Sporn et al., 1985) . Proteolytic processing of the provWF protein, as evidenced by release of the pro-polypeptide of the pro-vWF precursor, occurs at the arginine (763)-serine (764) peptide bond (Verweij et al., 1988) . Reeently, we have shown that furin, an endopeptidase with a specificity for dibasic amino acid residues, is able to specifically cleave pro-vWF at the indicated peptide bond (Van der Ven et al., 1990) . As yet, the intracellular location of furin in the endothelial cell is unknown, vWF secreted by the constitutive pathway is encountered as partially processed molecules. In contrast, vWF secreted upon stimulation with endothelial cell agonists is released by the Weibel-Palade bodies in a fully processed form.
The determination of the primary amino acid sequence of vWF, both by molecular cloning of the full-length cDNA and by direct amino acid sequencing, has revealed a pronounced structure of homologous domains, denoted A, B, C, and D, respectively (Sadler et al., 1985; Verweij et al., 1986; Shelton-Inloes et al., 1986; Bonthron et al., 1986; Titani et al., 1986) . The propolypeptide of the vWF, constituting the domains D1 and D2, is preceded by a signal peptide of 22 amino acids. The remainder of the vWF molecule encodes mature vWF, consisting of the domains D', D3, A1, A2, A3, D4, B1, B2, B3, C1, C2 and, finally, a carboxy-terminal stretch of amino acids exhibiting no internal homology. Recently, we and others have defined the domains involved in multimer assembly of vWF by expressing full-length vWF cDNA and mutants derived thereof in heterologous cells (monkey kid= ney COS-I) (Verweij et al., 1987 (Verweij et al., , 1988 Wise et ai., 1988; Voorberg et al., 1990) . Besides the involvement of the aminoterminal D domains in multimer assembly, we were able to show that multimer assembly can proceed independently of dimerization. Electron microscopy has implicated the carboxy-terminal part of vWF in dimerization, an observation further substantiated by Marti and co-workers who showed that, in vWF multimers derived from plasma, intermolecular disulfide bridges are located in the extreme carboxy-terminus beyond domain C2 (Fretto et al., 1986; Marti et al., 1987) . However, in those studies the involvement in dimerization of other domains at the carboxy-terminus of vWF has not been excluded. In this respect, it should be noted that the domains C1 and C2 may participate in this process as well, since the localization of cysteine residues corresponds with those of homologous domains on the oligomeric proteins, thrombospondin and procollagen (Hunt and Baker, 1987) . To obtain conclusive evidence on the domains of vWF involved in the assembly of dimers, we constructed a set of mutant vWF cDNAs and expressed these derivatives in COS-1 cells. The properties of the resulting mutant proteins with regard to dimerization are described. Furthermore, we have analyzed the routing of both wild-type and the mutant vWF proteins. Finally, the relationship between dimer-and multimer assembly and the routing of the different (mutant) vWF proteins through the cell will be discussed.
Materials and Methods

Materials
Restriction enzymes and DNA modifying enzymes were obtained from Bethesda Research Laboratories (Gaithersburg, MD).-The Sequenase kit was from the U.S. Biochemical Corp. (Cleveland, OH). Immunoreagents were either from the Central Laboratory of the Netherlands Red Cross Blood Transfusion Service (Amsterdam, The Netherlands) or from Dakopatts (Glostrup, Denmark). Radioactive chemicals were purchased from Amersham Radiochemical (Amershum, UK). Synthetic oligonuclcotides were prepared with an automated DNA synthesizer (model 381A; Applied Biosystems, Foster City, CA). Culture media and antibiotics were purchased from Gibco Laboratories (Paisley, UK) and from Flow Laboratories (Irvine, UK). Gelatin-Sepharose, Protein A-Sepharose, cyanogen bromideactivated Sepharose-4B, and plasmid pSVL were obtained from Pharmacia LKB (Uppsala, Sweden). Endoglycosidase H was obtained from Boehringer (Mannheim, FRG).
Plasmid Constructions
The plasmids pSVLvWF and pSVLE have been described previously (Voorberg et al., 1990) . A partial Eco [] digestion of pSVLE was performed to insert an Eco [] fragment containing the previously described mutant vWF cDNA that lacks the propolypeptide (Verweij et al., 1987) . The resulting plasmid was designated pSVLvWFdelpro. To construct a mutant eDNA lacking the domains C1 and C2 of vWE an 1,841-bp Bgl II-Eco [] fragment (position: 7065-8804) was subcloned into double-stranded M13mp9 phage DNA, digested both with Barn HI and Eco [] (Messing and Vieira, 1982) . The deletion of the domains C1 and C2 was made by using the M13-gapped duplex mutagenesis procedure (Kramer et al., 1984) . As an outloop-primer in this procedure, a synthetic oligonucleotide (36-met) was used (5'CTC.GAG.CGT.CTC. ATC. AC G.GAC. ACA .GTT.GCA .GC~. ACA. 3'). A clone that contained the desired deletion was selected and the complete sequence of a Sst I-Xho II fragment that contained the mutation was determined by dideoxy-sequencing using the Sequenase protocol (Vabor and Richardson, 1987) . The Sst I-Xho II fragment was inserted into the plasmid pSP8800vWF (Verweij et ai., 1986) and, subsequently, the mutant eDNA (lacking the domains C1 and C2) was inserted into the plasmid pSVLE yielding plasmid pSVLvWFdelC1C2. Plasmid pSVLvWFter2663, was constructed essentially according to the same protocol. As a template for mntagenesis, the M13mp9 phage with the 1,841-bp Bgl II-Eco [] insert described above, was used. The introduction of two point mutations, substituting the C for T at nucleotide 8216 and the T for A at nucleotide 8218, replaced the amino acid residue arginine at position 2663 by a translation termination codon. For that purpose an oligonueleotide primer (21-mer) (5'CGT.CTC. ATC.T*CA*.CTT.CAG.TGT3') was used that contained two substitutions (indicated with *) with regard to the wild-type sequence. The complete sequence ofa Sph I-Eco [] fragment containing the mutation was determined and, subsequently, the fragment was inserted into pSP8800vWE Finally, the vWF eDNA containing the mutation was inserted into plasmid pSVLE, yielding pSVLvWFter2663. The plasmid pSVLdelD1-C2 was constructed as follows. The M13mp9 clone that contained the 1,841-bp Bgl II-Eco [] insert described above was digested with Sal I. An Xho I fragment, ranging from the Xho I site in the poly-linker of pSVLvWF till the Xho I site at nucleotide position 1320 of the vWF cDNA, was inserted into the Sal I site. An M13 clone with the described Xho I fragment in the correct orientation was selected and the resulting construct, containing both the 5' end as well as the 3' end of the vWF eDNA, was used as a template for mutagenesis.
An oligonucleotide primer (36-mer) (5'CTG.GAG.CGT.CTC.ATC.ACG.-"IV_~.ACA.AAG.GGT.CCC.TGG.3') was used to fuse nueleotide 298 of vWF cDNA to nucleotide 8215 ofvWF eDNA. A selected clone, containing the desired mutation, was picked and the complete sequence of the vWF cDNA insert was determined. Next, an Eco [] fragment containing the entire mutated vWF eDNA was isolated and cloned into pSVLE, yielding pSVLvWFdelD1-D2. In this construct, the signal peptide ofvWF including the alanine-residue immediately beyond the signal peptide cleavage site is linked to the arginine at position 2663. DNA preparations, used for transfec: tion of monkey kidney cells (COS-l), were purified by cesium chloride/ ethidium-bromide equilibrium centrifugation.
1Issue Culture and Transfection
Monkey kidney COS-1 ceils were maintained in Iscove's modified minimal medium, supplemented with 100 U/ml penicillin, 100/~g/ml streptomycin, and 10% (vol/vol) FCS. 24 h after seeding, the semiconlluent cells were transfected with 40/~g of plasmid DNA in 4 ml of Iscove's modified minimal medium, supplemented with 200 #g/ml DEAE dextran. This incubation was followed by a chloroquine shock (Luthman and Magnusson, 1983) . After the transfection, cells were maintained in Iscove's minimal medium. As a control, cells transfected with pSV'2/t-PA DNA were used (Van Zonneveld et al., 1986) .
Metabolic Labeling of Transfected Cells
Transfected cells were maintained in serum-free medium for 70 h after transfection. At this time, the cells were starved for 1 h in RPMI medium, lacking either methionine or cysteine. The cell were labeled for 4 h in the same medium supplemented either with [~S]methionine (50 /~Ci/ml, specific radioactivity >800 Ci/mmol) or [35S]cysteine (50 t~Ci/ml, specific radioactivity >480 Ci/mmol), followed by a chase period of 16 h with nonlabeled methionine (30 #g/ml). After radiolabeliug, the medium was collected and centrifuged for 5 rain at 1,500 rpm. The calls were washed twice with 10 mbl sodium phosphate (pH Z4), 0.14 M NaCI (PBS) and lysed in immunoprecipitation buffer 0PB), consisting of 10 mM Tris-HC1 (pH 7.8), 150 mM NaCI, 5 mM EDTA, 1% (vol/vol) NP-40, 10 mM benzamidine, 5 mM N-ethy!maleimide and 1 mM PMSE Conditioned media and cell extracts obtained from metabolically labeled ceils were stored at -80"C or used immediately for immunoprecipitation. Pulse-chase experiments, spanning a shorter period, were performed essentially according to the above protocol.
Immunoprecipitation ~
Preclearing of media and cell extracts was performed by two successive incubations at room temperature with gelatin-Sepharose and, subsequently, with preformed complexes of rabbit preimmune serum coupled to protein A-Sepharose. Immunoprecipitation of radiolabeled vWF was carried out either by preformed complexes of an IgG preparation, derived from rabbit anti-vWF serum (Dakopatts) coupled to protein A-Sepharose or by using this anti-vWF serum coupled to cyanogen bromide-activated Sepharose.
Immunoprecipitates were extensively washed with immunoprecipitation buffer (IPB), pelleted through a discontinuous 10-20% (wt/vol) sucrose gradient and dissolved in IPB supplemented with 0.5 % desoxycholate and 10 mM Tris-HC1 (pH 7.8), respectively. After a final wash with 10 mM Tris-HC1 (pH ZS), the immunoprecipitates were analyzed by SDS-PAGE (Laemmli, 1970) .
vWF Multimer Analysis
Conditioned media of transfected cells was harvested three days after transfection. After centrifugation for 5 min at 1,500 rpm, the conditioned medium was adjusted to Ix IPB with 5 times concentrated IPB and then concentrated by Centricon-30 (Amicon Corp., Danvers, MA) filtration until a final concentration of 0.25 ng vWF/#I. Cell extracts of transfected cells were collected three days post transfection. An 80-cm 2 flask with transfected COS-1 cells was washed twice with PBS. Subsequently, the cells were scraped in PBS, collected by centrifugation and lysed in 250/~1 of IPB. Cellular debris was removed by centrifugation for 30 rain at 15,000 rpm and the resulting superrmtant was analyzed. Discontinuous SDS-agarose gel electrophoresis of 10-#1 samples of both medium and cell extract on a 0.8 % (wt/vol) agarose stacking gel and 2 % (wt/vol) running gel was performed as described previously (Ruggeri and Zimmerman, 1981) . After electrophoresis, the gel was fixed, dried and incubated with afffinity-purified []~I]-labeled rabbit anti-vWF IgG. The multimeric composition of the samples were visualized by autoradiugraphy. Partially cross-linked fibrinugen was used as a molecular weight marker (Verweij et al., 1987) . Multimeric analysis of the mutant protein vWFdelD1-C2 was performed by analyzing immunoprecipitates of metabolically labeled COS-I cells transfected with pSVLvWF'delDI-C2 under non-reducing conditions on a 15 % (wt/vol) SDSpolyacrylamide gel.
Endoglycosidase H Digestions
Endoglycosidase H (endo H) digestions were performed as follows. Cell extracts of transfected and metabolically labeled COS-I cells were immunoprecipitated as described. Sepharose beads, containing the immunopurified vWF, were incubated with ehition buffer (20 mM Tris-HC1 (pH 7.3), 1 mM PMSF, 10 mM EDTA, 10 mM benzamidine, 2 mM N-ethylmaleimide, 1% (wt/vol) SDS, 20 mM dithiothreitol) for 20 min at 600C. The resulting eluate was then diluted 10 times in incubation buffer (100 mM sodium acetate [pH 5.5], 1 mM PMSF, 10 mM EDTA, 10 mM benzamidine, 2 mM N-ethylmaleimide, 20 t~g/ml soybean trypsin inhibitor [SBTI], 0.1% [wt/vol] BSA) and digested with 50 mU/ml endo H for 16 h at 37"C. Endo H-digested samples were analyzed on a 5 % (wt/vol) SDS-polyacrylamide gel, in parallel with nondigested material and a mixture of digested and nondigested material.
Immunoelectronmicroscopy
Transfected COS-1 cells were maintained in serum-containing medium for 48 h after transfection. At this time the cells were fixed in a mixture of 4% paraformaldehyde and 0.5% ghitaraldehyde in 0. Figure 1 . Domain structure of the vWF protein and mutant proteins used in this study. The nomenclature of the repeated domains is according to Verweij et al. (1986) . The sites of the vWF protein that are cleaved during biosynthesis, behind the signal peptide and between the pro-polypeptide and the mature vWF subunit, respectively, are indicated by vertical arrows. Mutant proteins lacking specific domains or, alternatively, containing point mutations were constructed as indicated in Materials and Methods.
7.2). The cells were scraped from the dishes and embedded in 10% gelatin. Ultrathin frozen sections were prepared from the blocks and incubated with rabbit anti-vWF antiserum (Dakopatts; dilution 1:100) and gold-conjugated goat anti-rabbit IgG (Janssen Pharmaceutica, Beerse, Belgium; dilution 1:40, particle size 10 nm). Both incubations were done for ! h at room temperature. The sections were stained with uranyl acetate and embedded in methylcellulose. Other gelatin blocks were embedded at low temperature with Lowicryl K4M (Bio-Rad Laboratories, Veenendaal, The Netherlands). Thin sections were incubated with anti-vWF antiserum and gold conjugate as described above and stained with uranyl acetate and lead citrate. All the preparations were examined with a Philips CM 10 electron microscope.
Antigen Determination
The determination of the amount of vWF antigen in conditioned media was carried out by an ELISA, using rabbit anti-vWF IgG (Dakopatts) as a solidphase and a murine mAb against vWF (CLB RAg35), in conjunction with peroxidase-conjugated goat anti-mouse IgG, as a indicator (Reinders et al., 1985) . cells transfected with pSVLvWFter2663 reveals a weak band with a molecular weight in between that of the wild-type protein and that of the mutant protein vWFdelC1C2. This observation is in accordance with the length of the deletion (151 amino acids), constituting the extreme carboxy-terminus of vWF. Together, our results show that both mutant protein vWFdelC1C2 as well as mutant protein vWFter2663 are not secreted by COS-1 cells. Mutant protein vWFdelC1C2 is present at a level similar to that of wild-type vWF protein inside the cell, whereas the mutant protein vWFter2663 is present at a lower level inside the cell.
Results
Expression and Processing of vWF Mutant Proteins
Multimer Analysis of Mutant Proteins
The multimeric structure of the mutant proteins was examini~d by performing an electrophoretic analysis on 2% (wt/ vol) SDS-agarose gels (Fig. 3) . Staining of the gels was done by incubation with ~zSI-labeled anti-vWF antibodies. As shown before, wild-type vWF secreted by COS-1 cells is present as a multimeric structure (Verweij et al., 1987 (Verweij et al., , 1988 . Since both mutant protein vWFdelC1C2 and mutant protein vWFter-2663 are not secreted, multimer analysis of conditioned medium of ceils transfected with pSVLvWFdelC1C2 and pSVLvWFter2663 obviously did not reveal any signal (data not shown). Inspection of the multimeric pattern obtained for the wild-type protein from cell extracts also reveals the presence of the SV-40 "late" promoter. Transfected cells were metabolically labeled with [3sS]methionine and the secreted products were immunoprecipitated with anti-vWF antibodies and analyzed under reducing conditions by 5 % (wt/vol) SDS-PAGE to determine whether the level of expression and the pattern of proteolyfic processing was identical to that of wildtype vWF (Fig. 2 A) . As has been shown before, transfection of COS-1 cells with full-length vWF eDNA yields a mixture of pro-vWF-and mature vWF subunits (Bonthron et al., 1986; Verweij et al., 1987) . Surprisingly, however, no vWF protein could be immunoprecipitated from the conditioned media upon expression in COS-1 cells of the mutant cDNAs pSVLvWFdelC1C2 and pSVLvWFter2663. Subsequently, we analyzed cell extracts of metabolically labeled COS-1 cells transfected with the full-length and mutant cDNAs (Fig. 2 B) . As shown previously, in transfected COS-1 cells the wild-type protein is present in the nonproeessed form (Bonthron et al., 1986; Verweij et al., 1988) . Upon analysis of cell extracts of metabolically labeled COS-1 cells transfected with pSVLvWFdelC1C2, a single protein is immunoprecipitated which migrates slightly faster than the wild-type protein. The amount of the mutant protein vWFdelC1C2 encountered within the cell is similar to that of wild-type vWE The apparent molecular weight of this mutant protein coincides with the deletion of the domains C1 and C2 (i.e., 263 amino acids). Furthermore, like the wild-type protein, the mutant protein vWFdel-C1C2 is present intracellularly in the nonprocessed form. Since we were not able to detect the mutant protein vWFdelC1C2 in the conditioned medium of transfected COS-1 cells, we conclude that this mutant protein is defective in its secretion.
Analysis of cell extracts of metabolically labeled COS-1 of multimers. Since wild-type vWF is present in the cell extract exclusively in the nonprocessed form, only pro-vWF multimers are observed. The main form encountered for wild-type vWF is the dimer, whereas only a small portion is organized in multimers, in agreement with our previous observations (Verweij et al., 1987) . Several bands can be observed with a higher mobility than the wild-type pro-vWF dimer, most likely representing monomeric forms of wildtype vWF. The intraceUular, multimeric pattern obtained for the mutant protein vWFdelC1C2 is similar to that of the wildtype protein. As anticipated, the prominent vWFdelC1C2 dimer migrates slightly faster than the wild-type vWF dimer. These observations indicate that this mutant protein can dimerize and, consequently, is also able to multimerize, since the area involved in the latter process has been assigned to the distant amino-terminal D domains of the vWF molecule (Voorberg et al., 1990) . Hence, we conclude that the domains C1 and C2 do not participate in the formation of vWF dimers. Mnltimer analysis of cell extracts of COSA cells transfected with pSVLvWFter2663, reveals only one band which migrates significantly faster than the wild-type vWF and vWFdelC1C2 dimer. Clearly, the mutant protein vWFter2663 is not able to form dimers and is encountered within the cell as a monomer. This observation suggests that the region beyond domain C2 would be solely required for the generation of dimers.
Expression and Analysis of a Mutant vWF Protein Containing Only the Region beyond Domain C2
To demonstrate unambiguously that the region beyond C2 contains all the requirements for dimerization, a construct (pSVLvWFdelD1-C2) was made on which cDNAs are fused which encode the signal peptide and the utmost 151 carboxy-terminal amino acids of vWE Transfected COS-1 cells were metabolically labeled with [35S]cysteine and the secreted products were immunoprecipitated and analyzed under reducing conditions by 15 % (wt/vol) SDS-PAGE (Fig. 4  A) . A single protein is secreted and immunoprecipitated with the expected, apparent molecular weight of 20,000. Analysis of the secreted product under nonreducing conditions by 15 % (wt/vol) SDS-PAGE, yielded a protein with an apparent molecular weight of 40,000 (Fig. 4 B) , indicating the formation of a dimeric product linked by intermolecular disulfide bonds. Evidently, the region beyond C2 is capable of dimerization independent of the presence of other domains of the vWF molecule. This finding enables us to conclude that only the region beyond domain C2 of vWF is required for dimerization of vWE
A Defect in Assembly Results in Aberrant Transport of vWF Mutants through the Cell
In previous paragraphs, we have shown that the mutant protein vWFter2663 is unable to dimerize and present at a low level inside the cell. We investigated the fate of this protein inside the cell more closely, to obtain insight into routing of the protein as compared to wild-type vWF and vWFdelC1C2. Therefore, COS-1 cells transfected with pSVLvWF, pSVLvWFdelC1C2 and pSVLvWFter2663, were metabolically labeled for 1 h and followed by chase periods of different lengths. Both cell extracts and media, obtained after the different chase periods were irnmunoprecipitated and analyzed under reducing conditions by 5 % (wt/vol) SDS-PAGE (Fig. 5 ). Autoradiography revealed a gradual decrease of wild-type vWF in the cell, accompanied by a concomitant increase of secreted vWF, initiating after a chase of 4 h. After this period, a sharp decrease of the amount of wild-type protein inside the cell is observed. The fate of the mutant protein vWFdelC1C2 inside the cell exactly mimics that of the wildtype protein; again, the intracellular amount of this vWF protein sharply decreases after a 4-h chase. However, in contrast to the wild-type protein, for the mutant protein vWFdelC1C2 no concomitant increase of secreted vWF is observed. Even after a chase of 24 h, no secreted material can be detected for the mutant protein vWFdelC1C2, in accordance with the data presented in Fig. 2 . Clearly, mutant vWFdelC1C2 is defective in secretion and, consequently, the synthesized protein must be degraded inside the cell. Inspection of the pattern obtained for mutant protein vWFter2663, lacking the utmost 151 amino acids of vWF, reveals that until 4 h after synthesis this protein behaves identically to wildtype vWF. However, at chase periods longer than 4 h, the amount of vWFter2663 found in the cell deviates from the amount of wild-type protein. After 8 h, a significant reduction in the intraceUular amount of the mutant protein vWFter2663 is observed, compared with the wild-type protein, whereas 24 h after synthesis hardly any protein can be detected inside the cell (see Fig. 2 ). Combined with the observation that the mutant protein vWFter2663 is not secreted, we conclude that the mutant protein vWFter2663 is slowly degraded inside the cell, starting ,,~4-8 h after synthesis. Together, the above data provide evidence for the intracellular degradation of both mutant proteins vWFter2663 and vWFdelC1C2. However, the rate of degradation is different for both proteins. The mutant protein vWFdelC1C2 is degraded at a rate that approximately equals the rate of secretion of the wild-type protein. In contrast, mutant protein vWFter-2663, being unable to dimerize, is degraded at a much faster rate. This observation may indicate that the ability to assemble into dimers and, possibly to assemble into multimers, dictates the route followed within the cell. To test this option, we investigated the fate of a previously described mutant protein, vWFdelpro, which effectively forms dimers, but is unable to multimerize (Verweij et al., 1987) . Therefore, a pulse chase experiment was done with this mutant protein, performed identically to the one described above. Surprisingly, the mutant vWFdelpro displays a distinct higher secretion rate than the wild-type protein (Fig. 5) . As soon as 2 h after synthesis, a decrease of vWFdelpro in the cell extract is observed, accompanied by the concomitant appearance of the mutant protein in the medium. This observation indicates that the inability to form multimers leads to enhanced secretion. Consequently, a defect in protein assembly is not necessarily associated with degradation of a protein, as evidenced by mutant protein vWFter2663, which is unable to dimerize. Rather, the nature of the defect in protein assembly determines the fate of the protein.
Effect of lnhibitors of Lysosomal Function on the Degradation of Mutant Proteins vWFter2663 and vWFdelCIC2
In the previous paragraph, we have shown that both mutant protein vWFdelCIC2 and vWFter2663 are degraded inside the cell. Pulse-chase analysis revealed that mutant protein vWFdelC1C2 is degraded much slower than mutant protein vWFter2663. To define the intracellular site of degradation an identical pulse-chase experiment was carried out as described in Fig. 5 , however, in this case in the presence of different inhibitors of the lysosomal degradation pathway. Clearly, incubation of the cells with weak bases such as NI-LC1 and chloroquine, which inactivate lysosomal pro- Figure 6 . Effect of lysosomal inhibitors on the routing of wild-type vWF, vWFdelC1C2 and vWFter2663. Transfected COS-1 cells were metabolically labeled with 13SS]methionine for 1 h and chased for 0, 2, 4, 8, and 24 h, as indicated. During starvation, labeling and chase either 100/zM chloroquine, 50 mM NI-hCl, or no additions were present. Cell extracts were harvested, and the radiolabeled vWF was immunoprecipitated and analyzed on a 5% (wt/vol) SDS-polyacrylamide gel under reducing conditions. (A)Blanco; (B) incubation with 100 ~M chloroquine; (C) incubation with 50 mM NI-hC1. Only the relevant portions of the gels are shown.
teases, did not effect the routing of either wild-type vWF, vWFdelC1C2 and vWFter2663 (Fig. 6 ). These observations indicate that proteolytic degradation of the mutant proteins does not involve the lysosomes. In addition, incubation of transfected cells with yet another lysosomal inhibitor (leupeptin), again did not result in inhibition of proteolytic degradation of the mutant proteins vWFdelC1C2 and vWFter2663 (data not shown). Recently, the existence has been reported of a nonlysosomal pre-Golgi degradation route (LippincottSchwartz et al., 1988) . The insensitivity of proteolytic degradation of mutant proteins vWFdelC1C2 and vWFter2663 to inhibitors of the lysosornal pathway may indicate that both proteins are degraded via this pre-Golgi degradation route.
Endo H Digestions of Wild-1)~e and Mutant Proteins
To determine the intraceUular localization of the different vWF proteins, we tested the sensitivity of the wild-type and mutant proteins towards endo H. Sensitivity of the proteins for endo H means that the proteins have not reached the medial-Golgi, where maturation of asparagine-linked carbohydrate site chains occurs, resulting in endo H resistance (Komfeld and Kornfeld, 1985) . Therefore, transfected COS-1 cells were pulse labeled for 4 h with [3~Slcysteine and chased for 16 h. Endo H sensitivity of immunoprecipitated material derived of cell extracts was tested immediately after the pulselabeling and at the end of the chase-period (Fig. 7) . The wild-type protein is sensitive to endo H digestion after the 4 hour pulse (not shown) and even after a 16-h chase the wild-type protein present in the cell is entirely sensitive to endo H, indicating that the bulk of the vWF in the cell is retained in a compartment before the medial-Golgi. Inspection of the endo H sensitivity of secreted vWE revealed complete resistance to endo H digestion, as expected for a protein that has traversed the Golgi apparatus (data not shown). Mutant protein vWFdelC1C2, like the wild-type protein, remained sensitive to digestion with endo H after the 16-h chase. To analyze the mutant protein vWFter2663, we adjusted the chase period to 4 h, since the amount of this mutant protein in the cell rapidly decreases upon longer chase periods. Again, only endo H sensitive forms of the mutant protein vWFter2663 are encountered in the cell. In conclusion, the major part both of wild-type vWF and of the mutant proteins vWFdelC1C2 and vWFter2663, are retained in a compartment prior to the medial-Golgi.
Immunoelectron Microscopy of Valid-Type vWF and Mutant Proteins in Transfected COS-1 Cells
In the previous section, we have shown that both wild-type vWF and mutant vWF proteins are present in a compartment before the medial Golgi. To determine the localization of the wild-type and mutant proteins in the cell in more detail, immunoelectronmicroscopy was performed on ultrathin frozen sections and Lowicryl K4M sections of transfected COS-1 cells. Analysis of COS-1 cells, transfected with wild-type vWF cDNA, showed labeling of the cisternae of the RER (Fig. 8) . In Lowicryl K4M, thin sections (Fig. 8 A) , the reaction with ribosome-studded ER is clearly visible, although the intensity of labeling was weaker than on thin frozen sections (Fig. g, B and C) . No labeling was observed on the lysosomes, mitochondria, cytoplasm or the plasma membrane. Together with our biochemical data, this indicates that wild-type vWF is predominantly located in the RER. The mutant protein vWFdelC1C2 displayed a pattern identical to that of the wild-type protein. Also for this mutant protein label was exclusively associated with the RER (data not shown). Analysis of the localization of mutant protein vWFter2663, revealed that like the wild-type protein and vWFdelC1C2 this protein resides in the RER (Fig. 9, A and  B) . Again, no labeling of ly~osomes was observed, in agreement with the inability of lysosomal inhibitors to prevent degradation of the mutant proteins vWFdelC1C2 and vWFter-2663. Apparently, exit from the ER is a rate-limiting step both for the ultimate assembly of wild-type vWF multimers and for the degradative events associated with the mutant proteins vWFdelC1C2 and vWFter2663. During our morphological studies, on cells transfected with vWFter2663 cDNA, autophagosomes were detected, specifically labeled with anti-vWF antiserum (Fig. 9 C) . These structures consist of bodies that contained segregated portions of cytoplasm surrounded by a membrane. Vesicular and tubular elements (Fig. 9 C, inset) , reminiscent of segments of ER, labeled on their "lumenai" aspect, could be recognized in these autophagosomes.
In all experiments described, ,-5 % of the cells were transfected with plasmid DNA. The untransfected cells in the sections were observed as negative control for the specificity of the reaction. None of these ceils showed labeling with antivWF antiserum.
D i s c u s s i o n
Dimerization of vWF involves the formation of intermolecular disulfide-bridges at the carboxy-terminus of the vWF molecule (Fretto et ai., 1986) . A detailed inspection of the disulfide bridge organization of vWF derived with plasma reveaied that intermolecular disulfide bridges are located between amino acid residues 2689 and amino acid 2813 ofvWF (Marti et al., 1987) . The aforementioned study, however, did not exclude the presence of intermolecular disulfide bridges in the domains C1 and C2, since this region of the vWF was not covered in their studies. Recently, these domains have been implicated in oligomerization, based on the homology of this part of the vWF with the oligomeric proteins thrombospondin and procollagen (Hunt and Barker, 1987) . In this paper, we clearly show that a mutant protein, lacking the domains C1 and C2, is able to form dirners and conclude that this part of the molecule is not involved in dimerization of vWF. Both our results with the mutant protein vWFter2663, lacking the extreme carboxy-terminus of vWF, and vWFdelD1-C2 show that solely the utmost 151 carboxy-terminai amino acid residues of vWF are responsible for dimerization. Previously, we have shown that multimer assembly, in-volving intermolecular disulfide bonding at the amino terminus of vWF, requires only the amino-terminal D domains of vWF (Voorberg et al., 1990) . Together with our current observation on the involvement of the region beyond domain C2 in dimerization, the areas of vWF involved in the multimer assembly of vWF have now definitely been assigned.
The time course of vWF biosynthesis, dimerization, carbohydrate maturation and multimer assembly reveals remarkable features. The majority of vWF present in the cell is encountered in the dimeric form (Fig. 3) , indicating that the rate-limiting step in assembly is before or at the level of multimerization. In accord with this assumption are the data on the routing of vWFdelpro, a mutant unable to multimerize, and secreted significantly faster than wild-type vWF (Fig. 5) . In addition, both biochemical and morphological data of both wild-type vWF and the vWF mutant proteins demonstrate an accumulation of material in the ER. Since relatively few wild-type multimers are detected in cell extracts, we assume that upon a time-requiring initial multimerization process, these proteins are then rapidly, secreted. It should be noted that similar observations have been made on synthesis and assembly ofvWF in cultured vascular endothelial cells (Wagner and Marder, 1984) . Also in these cells, part of the vWF is encountered as endo H-sensitive material that is mainly present in the dimeric form. Hence, transfected COS-1 ceils serve as a suitable model system to study the constitutive secretory pathway for vWF-1 of endothelial cells, without interference of a regulated secretory pathway.
Our observations on the routing and the fate of the mutant protein vWFdelC1C2 are puzzling. Its properties to assemble into dimers and, subsequently, into multimers are similar to those exhibited by the wild-type protein. Despite its correct assembly, the mutant protein vWFdelC1C2 is not secreted, but instead degraded inside the cell. As yet we cannot present an explanation for the degradation of this mutant protein. It could be argued that the mutant protein vWFdelC1C2 is partly malfolded, and thus retained. Although we cannot fully exclude this possibility, the fact that this mutant protein is able to assemble into dimers and multimers, in our view argues against malfolding. Our morphological data clearly show that, like the wild-type protein, vWFdelCIC2 is predominantly present in the ER. After exit from the ER, the wild-type protein is transported rapidly through the Golgiapparatus to the outside of the cell. The proteolytic degradation of mutant protein vWFdelC1C2 is insensitive to inhibitor's of the lysosomal pathwhy (Fig. 5 ), in accord with our morphological data which dirt not reveal specific staining of lysosomes with polyclonal anti-vWF antibodies. Recently, a degradation route from the ER has been described for the a-chain of the T cell receptor, the H2 subunlt of the asialoglycoprotein receptor and a mutant of the serpin cxl-antitrypsin (Lippincott-Schwartz et al., 1988; Amara et al., 1990; Le et al., 1990) . In view of the properties of vWFdelC1C2, it is conceivable that this degradative route is pursued by this mutant protein. Numerous studies with oligomeric proteins, e.g., the asialoglycoprotein receptor, inununoglobulins, the T cell receptor and the influenza virus hemagglutinin, have indicated a close correlation between the assembly of a protein mad its routing through the cell (Bole et al., 1986; Copeland et al., 1988; LippincoWSchwartz et al., 1988; Amara et al., 1989; Doms et al., 1987 ). These studies demonstrate that a defect in the oligomer assembly of a protein results in retention or proteolytic degradation of the nonassembled product at the site of oligomer-assembly, i.e., the ER (Lodish, 1988) . The behavior of the mutant protein vWFter2663 strictly follows the pattern outlined above. The inability of this protein to undergo dimerization in the ER, its sensitivity to endo H and its relatively fast rate of degradation are compatible with the view that this protein is degraded from the ER. This assumption is further substantiated by insensitivity of the proteolytic degradation of vWFter2663 to inhibitors of lysosomal degradation. The linkage between assembly and routing is further illustrated by the properties of the mutant protein vWFdelD1-C2, containing only the region beyond domain C2. This mutant protein is able to assemble into dimers and, subsequently, readily transported from the ER, through the secretory pathway as evidenced by its appearance in the conditioned medium.
In this paper, we describe two mutant vWF proteins which conceivably are degraded from the ER. It has been suggested that autophagosomes may be the site of degradation from the ER (Lippincott-Schwartz et al., 1988) . Here, we report that in COS-1 cells transfected with pSVLvWFter2663, but not in COS-1 cells transfected with wild-type vWF, autophagosomes were detected which contain vWF (Fig. 9 C) . These observations are suggestive for a role of the autophagosome in degradation of this mutant protein from the ER. The properties of mutant protein vWFdelC1C2 indicate that this mutant protein is also degraded from the ER. However, in COS-1 cells transfected with vWFdelC1C2 no autophagosomes could be detected. Since the degradation of vWFdel-C1C2 proceeds much slower than that of vWFter2663, the number of autophagosomes present in the transfected COS-1 cell may significantly differ for these two mutant proteins. So far, morphological examinations have been limited by the frequency of vWF-transfected cells among the population of untransfected COS-1 cells. Currently, we are establishing stable cell lines expressing either wild-type vWF, vWFdel-C1C2 or vWFter2663, to enable a more thorough analysis of the relation between protein degradation from the ER and the occurrence of autophagosomes.
